Cargando…
Biomimetic Iron Complex Achieves TET Enzyme Reactivity
The epigenetic marker 5‐methyl‐2′‐deoxycytidine (5mdC) is the most prevalent modification to DNA. It is removed inter alia via an active demethylation pathway: oxidation by Ten‐Eleven Translocation 5‐methyl cytosine dioxygenase (TET) and subsequent removal via base excision repair or direct demodifi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518650/ https://www.ncbi.nlm.nih.gov/pubmed/34181314 http://dx.doi.org/10.1002/anie.202107277 |
_version_ | 1784584273593892864 |
---|---|
author | Schmidl, David Jonasson, Niko S. W. Korytiaková, Eva Carell, Thomas Daumann, Lena J. |
author_facet | Schmidl, David Jonasson, Niko S. W. Korytiaková, Eva Carell, Thomas Daumann, Lena J. |
author_sort | Schmidl, David |
collection | PubMed |
description | The epigenetic marker 5‐methyl‐2′‐deoxycytidine (5mdC) is the most prevalent modification to DNA. It is removed inter alia via an active demethylation pathway: oxidation by Ten‐Eleven Translocation 5‐methyl cytosine dioxygenase (TET) and subsequent removal via base excision repair or direct demodification. Recently, we have shown that the synthetic iron(IV)‐oxo complex [Fe(IV)(O)(Py(5)Me(2)H)](2+) (1) can serve as a biomimetic model for TET by oxidizing the nucleobase 5‐methyl cytosine (5mC) to its natural metabolites. In this work, we demonstrate that nucleosides and even short oligonucleotide strands can also serve as substrates, using a range of HPLC and MS techniques. We found that the 5‐position of 5mC is oxidized preferably by 1, with side reactions occurring only at the strand ends of the used oligonucleotides. A detailed study of the reactivity of 1 towards nucleosides confirms our results; that oxidation of the anomeric center (1′) is the most common side reaction. |
format | Online Article Text |
id | pubmed-8518650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85186502021-10-21 Biomimetic Iron Complex Achieves TET Enzyme Reactivity Schmidl, David Jonasson, Niko S. W. Korytiaková, Eva Carell, Thomas Daumann, Lena J. Angew Chem Int Ed Engl Research Articles The epigenetic marker 5‐methyl‐2′‐deoxycytidine (5mdC) is the most prevalent modification to DNA. It is removed inter alia via an active demethylation pathway: oxidation by Ten‐Eleven Translocation 5‐methyl cytosine dioxygenase (TET) and subsequent removal via base excision repair or direct demodification. Recently, we have shown that the synthetic iron(IV)‐oxo complex [Fe(IV)(O)(Py(5)Me(2)H)](2+) (1) can serve as a biomimetic model for TET by oxidizing the nucleobase 5‐methyl cytosine (5mC) to its natural metabolites. In this work, we demonstrate that nucleosides and even short oligonucleotide strands can also serve as substrates, using a range of HPLC and MS techniques. We found that the 5‐position of 5mC is oxidized preferably by 1, with side reactions occurring only at the strand ends of the used oligonucleotides. A detailed study of the reactivity of 1 towards nucleosides confirms our results; that oxidation of the anomeric center (1′) is the most common side reaction. John Wiley and Sons Inc. 2021-08-20 2021-09-20 /pmc/articles/PMC8518650/ /pubmed/34181314 http://dx.doi.org/10.1002/anie.202107277 Text en © 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Schmidl, David Jonasson, Niko S. W. Korytiaková, Eva Carell, Thomas Daumann, Lena J. Biomimetic Iron Complex Achieves TET Enzyme Reactivity |
title | Biomimetic Iron Complex Achieves TET Enzyme Reactivity
|
title_full | Biomimetic Iron Complex Achieves TET Enzyme Reactivity
|
title_fullStr | Biomimetic Iron Complex Achieves TET Enzyme Reactivity
|
title_full_unstemmed | Biomimetic Iron Complex Achieves TET Enzyme Reactivity
|
title_short | Biomimetic Iron Complex Achieves TET Enzyme Reactivity
|
title_sort | biomimetic iron complex achieves tet enzyme reactivity |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518650/ https://www.ncbi.nlm.nih.gov/pubmed/34181314 http://dx.doi.org/10.1002/anie.202107277 |
work_keys_str_mv | AT schmidldavid biomimeticironcomplexachievestetenzymereactivity AT jonassonnikosw biomimeticironcomplexachievestetenzymereactivity AT korytiakovaeva biomimeticironcomplexachievestetenzymereactivity AT carellthomas biomimeticironcomplexachievestetenzymereactivity AT daumannlenaj biomimeticironcomplexachievestetenzymereactivity |